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Shared idiotypes in mesangial deposits in IgA nephropathy are not
disease.specific. The antigenic specificity of the mesangial IgA in IgA
nephropathy (IgAN) remains unknown. Because shared antigenic spec-
ificities may be reflected in the usage of shared idiotypes, we prepared
five monoclonal anti-idiotypic antibodies (MoAbs) specific for the
mesangial IgA eluted from the kidney of an IgAN patient. All five
MoAbs reacted with the same idiotype, which proved to be of a public
nature. Although the idiotype could be identified in the mesangial
deposits of the majority of IgAN patients studied, it was not specific for
the disease because it was also found in the glomerular deposits of other
types of glomerulonephritis. The idiotype was also expressed in poly-
ethylene glycol precipitates of sera and in pokeweed mitogen-induced
plasma cells from both IgAN patients and healthy controls. The
conclusion that no disease-specific idiotypes are present in the renal
eluate was further supported by the failure to produce polyclonal
anti-idiotypic antibodies by immunizing a rabbit with the eluted mesan-
gial IgA. Our results support the concept that mesangial IgA deposits in
IgAN are of a polyclonal nature.
Primary IgA nephropathy (IgAN) has been found to be the
most common form of primary glomerulonephritis in different
areas of the world [1]. Despite twenty-five years of investiga-
tion, the pathogenesis of this disease remains enigmatic. Al-
though a hyperresponsiveness leading to an increased produc-
tion of IgAl and elevated levels of IgAl in the circulation
appears to play an important role, this mechanism does not
provide an adequate explanation for the disease [2—7]. An
increased level of IgAl in the circulation in itself is certainly
insufficient to cause the characteristic mesangial IgAl deposi-
tion [8—10]. This is clearly illustrated by the infrequency of
mesangial IgA deposits in other conditions with elevated levels
of circulating IgAl, such as IgA 1 myeloma and HIV infection
[11—17]. It is likely that an as yet undefined characteristic of the
circulating IgAl is of paramount importance in determining
whether it will deposit in the mesangium. Theoretically, this
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characteristic could be either a chemical alteration in the
constant portion of the IgAl molecule, or alternatively, it could
be related to the antigenic specificity of the variable region.
With regard to the latter, numerous investigators have at-
tempted to identify the antigenic specificity of the mesangial
IgAl. Such studies have focused on serum levels of IgA
antibodies directed at environmental antigens, and on the
potential presence of mesangial antigens. Neither of these
approaches has yielded an unambiguous indication of a specific
antigen involved in the pathogenesis of the disease [reviewed in
18]. An alternative approach to the identification of a disease-
related antigen is the study of the idiotypes expressed in the
mesangial deposits. Sharing of antibody idiotypes in different
patients with IgAN might provide us with a clue as to what the
relevant antigen or antigens might be, especially if such idio-
types proved to be disease-specific [19, 20].
We recently had the opportunity to elute the mesangial IgA
from a nephrectomy specimen of a patient with IgAN and
produced polyclonal and monoclonal antibodies to this eluted
IgA in an attempt to identify disease-related idiotypes.
Methods
Kidney eluate
In 1985, nephrectomy was performed because of severe
persistent bleeding after a percutaneous biopsy of the left
kidney of a 45-year-old White male. The patient had presented
with impaired renal function (creatinine clearance 29 ml/min)
and hypertension, and the pathological diagnosis was primary
IgAN with glomerular and interstitial scarring. There were no
clinical or laboratory signs of SLE, Henoch-SchOnlein purpura
or chronic liver disease. The kidney was perfused with 750 ml of
heparanized phosphate buffered saline (PBS) to remove blood.
Intrarenal hematoma was dissected out, and the renal cortex
was isolated. One half of the cortical tissue was used to isolate
glomeruli using conventional sieving methods, the other half
was directly processed for elution. The isolated glomeruli were
washed and subsequently eluted (1 hr at room temperature)
with 2 M potassium thiocyanate in phosphate buffer (0.01 M, pH
7.6). To inhibit proteolysis and denaturation the elution buffer
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Table 1. Composition of renal eluates
Renal eluate
Total protein IgA lgG 1gM
isgiml
Renal cortex 1140 37.6 72.0 18.0
Glomeruli 1420 5.7 10.8 0
Composition of the renal eluates obtained from intact renal cortex,
and from isolated glomeruli. Total protein concentration was measured
by the modified Lowry method. Concentrations of IgA, IgG, and 1gM
were measured by ELISA.
also contained EDTA (2mM), aprotinin 0.5 U/liter (Bayer A.G.,
Leverkusen, Germany), and 5% glycerol. The elution of the
intact cortex was performed by homogenization of the tissue,
followed by washing of the pelleted material with PBS contain-
ing EDTA (2 mM), aprotinin (0.5 U/liter) and phenyl methyl
sulphonyl fluoride (0.25 mM; Sigma Chemical Company, St
Louis, Missouri, USA). Acid elution was performed for two
hours at 4°C with 0.02 M citrate buffer (pH 3.2), containing 5%
glycerol, EDTA (2 mM), aprotinin (0.5 U/liter) and NaCl
(sufficient to adjust conductivity to 25 mS). Both eluates were
extensively dialyzed against Veronal-buffered saline containing
5% glycerol. Table I provides some characteristics of the two
eluates. Total protein content was measured with a modified
Lowry method (Pierce Chemical Company, Rockford, Illinois,
USA). The immunoglobulin concentrations were determined by
enzyme-linked immunosorbent assay (ELISA).
Generation of polyclonal anti-idiotypic antibodies
We first tried to identify IgAN-specific mesangial idiotypes
by raising a polyclonal antiserum. The IgAl was isolated from
30 ml of the renal cortical eluate by 50% ammonium sulfate
precipitation, followed by affinity chromatography on a column
of immobilized jacalin [21]. A rabbit was immunized with 23 g
of the purified IgAl in complete Freund's adjuvant. Two
booster immunizations of 12 g each in complete Freund's
adjuvant were given two and three weeks after the initial
injection. Sera were obtained weekly after the second booster,
and an immunoglobulin fraction was prepared after heat inac-
tivation (30 mm at 56°C) of the sera by 33% ammonium sulfate
precipitation. Reactivity with normal human serum was re-
moved by chromatography on immobilized human immunoglo-
bulins (a gamma globulin fraction obtained through 33% ammo-
nium sulfate precipitation of normal human sera). Anti-idiotypic
(anti-Id) reactivity was tested by ELISA. Microtiter plates were
coated with either 1 pgIm1 of the purified IgAl from the renal
eluate or 2 g/ml of normal human immunoglobulin in carbon-
ate buffer (pH 9.6) overnight at 4°C. Column fractions, diluted
1:5 in PBS containing 0.05% Tween 20 (Sigma) (PBS-Tween),
were added to the wells and incubated for one hour at 37°C.
Bound rabbit IgG was detected with a goat anti-rabbit IgG
antibody coupled to peroxidase (1 hr at 37°C), followed by the
substrate o-phenylenediamine (Sigma).
Generation of monoclonal anti-idiolypic antibodies
The second approach to identify IgAN-specific idiotypes
consisted of raising monoclonal antibodies to the mesangial
IgA. The IgA in the renal cortical eluate was purified by
absorption to Sepharose CL-4B beads (Pharmacia Fine Chem-
icals, Piscataway, New Jersey, USA) coupled to a MoAb
directed at human IgA (clone 145.11-1, generated in our labo-
ratory; approximately 6 mg MoAb/ml gel). Five ml of the eluate
was mixed with 0.5 ml of the packed beads, and rotated for 72
hours at 4°C. Mter extensive washing with PBS, 0.3 ml of the
beads suspended in 0.3 ml of PBS were emulsified in an equal
volume of complete Freund's adjuvant and 0.3 ml of the
emulsion was injected intramuscularly in the thigh and the
abdominal subcutis of 8- to 12-week old BALB/c mice (Charles
River Breeding Laboratories, Raleigh, North Carolina, USA).
The immunization followed the protocol described by Lieber-
man et al [22], with slight modification. Serum samples taken at
three weeks after the immunization were positive for anti-
human IgA antibodies as determined by ELISA. The mice
received a booster injection of the IgA-coupled beads sus-
pended in incomplete Freund's adjuvant, and one week later
the spleen and inguinal lymph nodes were removed. A single
cell suspension was prepared and fused with the non-secreting
mouse myeloma line P3X63-Ag8.653 according to established
methods [231. After fusion the cells were seeded into 24-well
tissue culture plates (Costar, Cambridge, Massachusetts, USA)
in plating media consisting of RPMI 1640 (Mediatech, Wash-
ington, D.C., USA) with 10% heat-inactivated fetal bovine
serum (Flow-ICN, Costa Mesa, California, USA), 5 x i0 M
2-mercaptoethanol, 100 U/ml penicillin, 100 pg/ml streptomy-
cm, and HAT (Flow-ICN). Fusions were fed with culture media
three times during the 14-day incubation period. The last
feeding, performed 48 hours prior to screening, consisted of a
complete change of media to assure the removal of residual
antibody. Supernatants were screened for anti-Id activity by
ELISA. Positive cell lines were cloned by limiting dilution on
feeder cells obtained from the peritoneal cavity of pristane-
primed mice. Cloned cell lines were raised as ascites in pris-
tane-primed BALB/c mice.
Supernatants from six out of 250 wells showed preferential
activity for the renal eluate. Of these six lines, five were cloned
and grown as ascites.
Screening of hybridomas by ELISA
This assay was used to identify clones showing preferential
reactivity with the mesangial IgA, possibly through IgAN-
specific idiotypes. Polyvinylchloride microtiter plates
(Dynatech Laboratories, Chantilly, Virginia, USA) were coated
overnight at room temperature with 100 j.dlwell of affinity-
purified heavy chain specific goat F(ab')2 anti-human IgA (Pd
Freez, Rogers, Arkansas, USA). The antibody had previously
been extensively absorbed to immobilized mouse immunoglob-
ulin, and was diluted to 1 ig/ml in PBS (pH 7.2). After washing
with PBS, the wells were blocked for three hours at 37°C with
200 tdIwell of PBS containing 5% bovine serum albumin (BSA,
Sigma). IgA from different sources was subsequently added to
the wells in a volume of 100 d at a concentration of 200 nglml,
diluted in PBS-Tween with 1% BSA (PBS-Tween-BSA). The
IgA was allowed to bind overnight at 4°C, and the wells were
washed three times with PBS-Tween. Hybridoma supernatants
were incubated in the wells for two hours at 37°C, using
PBS-Tween-BSA, normal mouse serum at a 1:400 dilution, and
culture media as blanks. After washing with PBS-Tween, bound
mouse immunoglobulin was detected with a biotinylated goat
F(ab')2 anti-mouse immunoglobulin (Southern Biotechnology
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Associates, Birmingham, Alabama, USA), which had been
previously absorbed to immobilized human immunoglobulin.
This antibody was diluted in PBS-Tween-BSA, and incubated
for two hours at 37°C, or overnight at 4°C. The plates were
washed with PBS-Tween, and incubated with avidin-conjugated
peroxidase (Sigma) for one hour at 37°C. Conversion of the
substrate (2,2'-azino-bis [3-ethylbenzthiazoline-6-sulfonic acid];
(Sigma), containing 0.0075% H202) was measured at 414 nm on
a maX kinetic microplate reader (Molecular Devices Co., Palo
Alto, California, USA). The selection of hybridomas containing
possible anti-Id murine antibodies was based on an OD which
was higher, by a factor of two or more, in wells containing IgA
from the eluate of the intact cortex, compared to wells contain-
ing IgA from pooled normal human sera.
ELISA for screening of anti-Id MoAbs on a panel of human
monoclonal proteins
Reactivity with a human paraprotein panel was used to
establish the anti-Id nature of the MoAbs that preferentially
bound to the mesangial IgA. All five anti-Id MoAbs grown as
ascites were of the IgG1 kappa isotype. Reactivity of the
MoAbs with a panel of 48 human monoclonal proteins (19 1gM,
11 IgG, and 11 IgA myeloma proteins, and 7 Bence Jones
proteins) was determined by ELISA. The monoclonal proteins
were coated onto polystyrene microtiter plates (Linbro/Titer-
tek, Flow Laboratories, McLean, Virginia, USA) either di-
rectly, diluted in PBS at 10 gfml, or through the goat F(ab')2
anti-human IgA as a capturing antibody as described above, for
the IgA myeloma proteins. Subsequently, the wells were
blocked with PBS-Tween-BSA and incubated for two hours at
37°C with ascites of the anti-Id MoAbs, diluted in PBS-Tween-
BSA. Bound mouse IgG was detected with a biotinylated goat
F(ab')2 anti-mouse immunoglobulin as outlined above. Positive
reactions were defined by an OD at least fourfold higher than
obtained in control wells containing normal mouse serum
diluted 1:1000 in PBS-Tween-BSA instead of the MoAb.
Cross-inhibition ELISA of the five anti-Id MoAbs
This assay was used to establish whether the five anti-Id
MoAbs reacted with different idiotypic epitopes, or with a
single one. In order to study epitope-specificity of the five
anti-idiotypic MoAbs, we assessed the capacity of the MoAbs
to inhibit the binding of one of them (MoAb 133.5) to one of the
monoclonal proteins expressing the idiotype (1gM Dau). Poly-
styrene microtiter plates were coated overnight at room tem-
perature with 100 j.d/weIl of the 1gM protein at 10 pg/ml in PBS,
followed by washing and blocking. Increasing concentrations of
ascites from the five MoAbs were added to an appropriate
dilution of biotinylated MoAb 133.5 in PBS-Tween-BSA. To
duplicate wells, we added 100 pi of the inhibition mixtures, and
incubated the plates for two hours at 37°C. After washing with
PBS-Tween, the amount of bound biotinylated MoAb 133.5 was
measured using avidin-conjugated peroxidase as outlined
above. The OD in the inhibition mixtures was expressed as a
percentage of the OD in wells containing biotinylated MoAb
133.5 only.
Immunoblotting
Reactivity of the MoAb anti-Id 133.5 with human monoclonal
proteins was assessed by immunoblotting, following published
methods with minor modifications [24]. This technique was
used to distinguish between idiotypes expressed on the immu-
noglobulin heavy and light chains. Each monoclonal protein (10
s1 at 1 mg/nil) was reduced by incubation (1 hr at room
temperature) with 5 j.d of 0.03 M dithiothreitol, followed by
alkylation with 5 tl of 0.16 M iodoacetamide (30 mm at room
temperature, and overnight at 4°C). Subsequently, the samples
were diluted 1:2 in 0.175 M Tris-HC1 buffer (pH 6.8), containing
20% glycerol, 4% sodium dodecyl sulfate, and 0.0025% bromo-
phenol blue, and heated to 95°C for one minute. The samples
were electrophoresed in 12% polyacrylamide gels, followed by
transfer to nitrocellulose membranes by electroblotting. The
nitrocellulose membranes were blocked by overnight incuba-
tion with normal mouse serum, diluted 1:200 in PBS, followed
by an overnight incubation with biotinylated MoAb 133.5, and
a one hour incubation with avidin coupled to alkaline phos-
phatase. A duplicate blot was incubated with rabbit anti-human
immunoglobulin, followed by alkaline phosphatase-coupled
goat anti-rabbit IgG. The membranes were stained with 5-bro-
mo-4-chloro-3-indolyl phosphate p-toluidine salt and nitro blue
tetrazolium (Sigma).
Immunofluorescence of plasma cells
Expression of the idiotype 133.5 was studied in pokeweed
mitogen (PWM)-induced plasma cells in IgAN patients and
healthy controls to further establish the anti-Id nature of the
MoAb, and to examine the relative frequency of the Id in the
two groups. Peripheral blood mononuclear cells were isolated
from heparinized blood from eight IgAN patients and six
controls using a standard Ficoll density gradient. The cells were
washed twice in PBS, and once in complete tissue culture media
consisting of RPMI 1640 (Mediatech) supplemented with 2 mM
L-glutamine (Gibco BRL, Grand Island, New York, USA),
penicillin (100 U/nil) and streptomycin (100 /Lg/ml; Gibco), and
10% heat-inactivated fetal bovine serum (FIow-ICN). Cells
were cultured at 1 x 106/ml in complete tissue culture media
containing 1:100 PWM (Gibco) for seven days at 37°C in
humidified air containing 5% CO2. The cells were harvested and
used to make cytospin preparations. The percentage of idio-
type-expressing plasma cells within each isotype was deter-
mined by two-color immunofluorescence following established
methods [4, 51. Fixed cytospin slides were incubated with
MoAb 133.5 ascites diluted 1:400 in PBS containing 1% BSA for
30 minutes, followed by goat anti-mouse IgG coupled to tetra-
methyirhodamine isothiocyanate (TRITC) (Southern Biotech-
nology Associates), which had been previously absorbed on
human immunoglobulins. The cells were counterstained with
fluorescein isothiocyanate (FITC)-labeled isotype-specific goat
anti-human immunoglobulin antibodies (Southern Biotechnol-
ogy Associates), which had been previously absorbed to mouse
IgG. The percentage of idiotype 133.5-expressing plasma cells
within the various isotypes (total Ig, IgG, IgA, 1gM, kappa, and
lambda) was determined by counting at least 400 plasma cells in
each preparation. The final result is given as the mean percent-
age of plasma cells of each isotype that was positive for the
idiotype. As a negative control, normal mouse serum diluted
1:100 was substituted for the MoAb 133.5 in the staining
procedure, yielding a frequency of positive plasma cells of less
than 1 in 2000 in all slides.
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Immunofluorescence of kidney biopsies
Presence of the idiotype 133.5 in glomerular deposits was
established by two-color immunofluorescence microscopy on
frozen sections of kidney biopsies obtained from the files of the
Department of Pathology at Leiden University. We included
sections from the following categories of patients: 31 IgAN, six
recurrent IgAN after renal transplantation, six Henoch-Schon-
lein purpura, eight lupus nephritis, seven idiopathic membra-
nous nephritis, five membranoproliferative glomerulonephritis,
and four cases of glomerulonephritis associated with essential
mixed cryoglobulinemia. Sections were fixed in 95% ethanol
containing 5% glacial acetic acid for 20 minutes at —20°C, and
washed in PBS. Staining for the idiotype 133.5 was performed
as outlined above for plasma cells, with counterstaining for
human IgA. The sections were scored by two independent
observers on a scale of 0 to 3+. As a negative control, normal
mouse serum diluted 1:100 in PBS was substituted for the
MoAb 133.5, yielding negative findings in all biopsies. MoAb
133.5 also did not stain normal human kidney sections.
Percentage of the IgA in the eluates expressing the idiolype
The contribution of the idiotype 133.5 in the renal eluates was
determined by affinity chromatography. Purified MoAb 133.5
was linked to Bio-Gel A-S beads (Bio-Rad, Richmond, Califor-
nia, USA). Bio-Gel A-S linked to BSA served as a control
immunoabsorbent. Aliquots of the renal cortex eluate, the
eluate obtained from isolated glomeruli, and the IgA myeloma
Car (which carries the idiotype 133.5) were diluted in PBS-
Tween-BSA to obtain an IgA concentration of 5 g/m1. The
samples were absorbed for 72 hours at 4°C to an equal volume
of either the active or the control absorbent. After centrifuga-
tion, the supernatants were assayed by ELISA for total IgA
content, and for IgA expressing the idiotype 133.5 following the
procedure outlined above. The depletion of total IgA and
idiotype is expressed as a percentage of the values obtained
before absorption.
Presence of the idiotype in PEG precipitates
This assay was used to see whether the mesangial Id was also
present in circulating immune complexes. The quantity of IgA
expressing the idiotype 133.5 was determined in 3.5% polyeth-
ylene glycol (PEG, Sigma) precipitates of sera from 19 IgAN
patients (mean age 37 years; serum creatinine concentration
> 110 mol/liter in 9 patients) and 19 healthy controls (mean
age 33 years). Polyvinylchloride microtiter plates (Dynatech)
were coated with a MoAb against human IgA (clone CH-E
B6.8, gift from Dr. J. Kearney). PEG precipitates were diluted
in PBS-Tween-BSA, and incubated in the wells for two hours at
37°C. After washing, the idiotype was detected with biotiny-
lated MoAb 133.5, by incubation for two hours at 37°C,
followed by avidin-conjugated peroxidase as outlined above. As
a standard, a dilution series of the idiotype-expressing IgA
myeloma Car was included on each plate. The resulting con-
centration of idiotype-positive IgA, in arbitrary units/mi, was
obtained by interpolation. In parallel, the total IgA concentra-
tion of the PEG precipitates was determined by ELISA, to
allow expression of the results in arbitrary units per g of IgA.
Column fraction number
Fig. 1. Binding of rabbit anti-Id to renal eluate IgA (•) and normal
immunoglobulin (0). The rabbit antibodies were absorbed on normal
human immunoglobulins, and the column fractions assayed for binding
to IgAl purified from the renal eluate and to normal immunoglobulins
by ELISA.
Results
Polyclonal anti-idiotypic antibodies
Rabbit antibodies reacting both with normal human serum
IgA, and the IgAl purified from the renal cortex eluate were
raised. Affinity absorption on a human immunoglobulin column
was performed to render the antiserum selective for possible
idiotypic determinants in the renal eluate. As shown in Figure 1,
there was no preferential binding of the fractions not retained
on the affinity column to the renal IgA as compared with normal
serum immunoglobulins after the absorption.
Monoclonal anti-idiotypic antibodies
Five clones that were generated displayed preferential bind-
ing to the renal eluate IgA. Such preferential binding was
demonstrated in both the eluate obtained from the intact renal
cortex and the eluate obtained from isolated glomeruli. All five
MoAbs also showed binding, albeit with lower intensity, to
normal human IgA present in pooled serum or colostrum. The
idiotypic specificity of the five clones was established by
screening on a panel of human monoclonal immunoglobulins.
Reactivity was not linked to heavy chain class and limited to a
subgroup of kappa light chain-expressing proteins, supporting
the anti-idiotypic nature of the MoAbs (Table 2) [25, 261. All
five MoAbs recognized the same proteins, suggesting specificity
for the same epitope. This was further supported by the finding
of dose-dependent cross-inhibition of binding among the vari-
ous idiotype-expressing monoclonal proteins (results not
shown). Although the number of monoclonal proteins examined
that express lambda light chains is rather small, the results
suggested that the idiotype may be restricted to proteins that
contain kappa chains. Further confirmation of the anti-idiotypic
nature of the five MoAbs came from studies using isolated
F(ab')2 fragments obtained from one of the IgA myeloma
proteins (Pet) with which the MoAbs reacted. All five MoAbs
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Table 2. Reactivity of the five anti-Id MoAbs with myeloma proteins
Number
Paraprotein type
Number
examined
reactive
with MoAbs
1gM 19 6
IgG 11 0
IgA 11 2
Bence Jones protein (all kappa) 7 0
Kappa-containing paraproteins 39 8
Lambda-containing paraproteins 9 0
Reactivity with the monoclonal immunoglobulins was assessed by
ELISA. Proteins were coated directly, or through anti-IgA as a capture
antibody. Binding of the MoAbs was measured using biotinylated
goat-anti-mouse immunoglobulin.
also proved to be reactive with the F(ab')2 fragments in ELISA,
demonstrating that binding occurred within the fragment con-
taining the variable region (results not shown). Finally, the
reactivity of the five MoAbs with plasma cells of different
isotypes and light chain types supports that the determinant
recognized is indeed an idiotype (Table 3). Expression of the
idiotype is comparable between the various isotypes, but is
limited to cells expressing kappa light chains. Further screening
in ELISA suggested an association between the 133.5 idiotype
and the Vkappa3a family of light chains. MoAb 133.5 reacted
with all 6 Vkappa3a proteins examined, and with none of 11
Vkappa3b, 3 Vkappal, 2 Vkappa2, or 2 Vkappa4 proteins.
MoAb 133.5 was also reactive with 2 IgA myeloma proteins
(Pet and Car) whose V regions have not been typed.
Cross-inhibition of the MoAbs anti-Id
The binding of biotinylated MoAb 133.5 to the idiotype-
positive monoclonal 1gM Dau was inhibited by increasing
concentrations of unlabeled MoAb 133.5 and the other four
MoAbs anti-Id. The inhibition curves proved to be parallel,
strongly suggesting that all five share specificity for the same
idiotypic determinant (Fig. 2).
Immunoblotting
The binding of biotinylated MoAb 133.5 to monoclonal
proteins was further examined in immunoblots. No binding was
observed after reduction and alkylation in five proteins (2 IgA,
3 1gM) which were negative in the idiotype-specific ELISA.
With respect to three 1gM kappa monoclonal proteins (Porn,
Cor, Dau) which reacted with 133.5 in ELISA, binding in the
immunoblots was found to be restricted to the light chain. The
IgA kappa myeloma Car, which was reactive with MoAb 133.5
in ELISA, did not bind MoAb 133.5 in the immunoblot,
suggesting that the epitope recognized was denatured by the
reduction.
Imrnunofluorescence of kidney biopsies
The idiotype 133.5 was detected in the glomerular deposits
with an intensity of 1 + or greater in 26 of the 31 IgAN biopsies
(84%). The pattern of staining was found to be virtually identi-
cal to that obtained with the anti-IgA conjugate. Similarly,
idiotype 133.5 could be detected in the mesangial deposits of all
six biopsies from patients with recurrent IgAN after renal
transplantation, and in all six patients with Henoch-SchOnlein
purpura (Table 4). However, the idiotype could also be detected
with a similar prevalence in the glomerular deposits of the other
types of glomerulonephritis examined, demonstrating that the
finding of idiotype 133.5 is not specific for IgAN. Figure 3
shows typical results of the staining for idiotype 133.5 in renal
biopsy sections from patients with various types of glomerulo-
nephritis.
Frequency of idiotype-positive plasma cells in IgAN patients
and controls
The idiotype 133.5 could be found in PWM-induced plasma
cells from both IgAN patients and healthy controls (Table 3).
Expression was not linked to any particular heavy chain class,
but was virtually restricted to plasma cells expressing kappa
light chains, confirming the restriction found in ELISA. IgAN
patients did not have higher frequencies of idiotype-positive
plasma cells than healthy controls.
Percentage of the IgA in the eluates expressing idiotype 133.5
Depletion of idiotype 133.5 by affinity chromatography re-
sulted in the removal of 16% of the total IgA in the glomerular
eluate, and no appreciable removal of IgA from the eluate
obtained from the intact renal cortex (Table 5). The complete-
ness of the absorption was assured by the results of the ELISA
measuring idiotype-expressing IgA, which demonstrated com-
plete removal from the eluates. Likewise, the simultaneously
performed absorption of the idiotype-positive IgA myeloma
protein Car showed that the procedure was technically ade-
quate. The results of the absorption experiments strongly
suggest that the contribution of idiotype 133.5 in the renal
eluates is relatively minor.
Presence of the idiotype in PEG precipitates
IgA bearing the idiotype 133.5 could be demonstrated in PEG
precipitates of sera from IgAN patients and healthy controls. In
IgAN patients the level was 1024 1135 arbitrary units/ml
(mean SD), and in healthy controls 861 894 U/mi. No clear
relationship with renal function could be discerned in the
patient group. Although the absolute quantity of IgA expressing
idiotype 133.5 was somewhat higher in patients than in controls,
the level was not elevated in the patients when expressed per g
of total IgA present in the precipitate (25 10 U/pg in IgAN, 34
15 U/tg in controls).
Discussion
The antigenic specificity of the mesangial IgAl in IgAN has
remained unclear despite numerous investigations [reviewed in
18]. Clearly, our understanding of the pathogenesis would be
greatly enhanced by the identification of the endogenous or
exogenous antigens involved. In this study, we have attempted
to identify disease-related idiotypes by generating anti-idiotypic
antibodies to IgA eluted from a kidney removed from a patient
with IgAN. The rationale for this approach is that a common
antigenic specificity or restricted clonality in the mesangial IgA
deposits may lead to the presence of shared idiotypes between
IgAN patients [19, 20].
Using hybridoma technology, we succeeded in generating
five MoAbs with idiotypic specificity, directed against an
epitope present in the mesangial IgA of our patient. The
anti-idiotypic nature of these MoAbs was established by the
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Table 3. Expression of idiotype 133.5 in plasma cells
Group
Total Ig
(all plasma cells) IgG IgA 1gM Kappa Lambda
IgAN (N = 8) 6.4 1.1 5.8 1.4 4.6 0.9 5.4 1.9 8.6 2.5 0.15 0.18
Control (N = 6) 6.2 1.8 5.0 1.3 6.2 2.0 5.6 1.5 8.5 2.4 0.05 0.09
Data are the percentages (mean SD) of plasma cells within each isotype that express the idiotype 133.5.
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Fig. 2. Cross-inhibition of the five anti-Id MoAbs. Inhibition of the
binding of biotinylated MoAb 133.5 to monoclonal 1gM protein Dau by
increasing concentrations of unlabeled MoAbs in ELISA. The binding
is expressed as percentage of the OD obtained in the absence of
inhibitor. Symbols are: (•) 129A8; (•) 21.24-4; (0)131.7; (LO 129.16;
(A) 133.5.
screening on human monoclonal immunoglobulins, which
showed recognition independent of heavy chain isotype, and
limited to a minority of the kappa light chain isotype. Further
confirmation came from the demonstration of binding to F(ab')2
fragments of one of the monoclonal proteins, and the immuno-
fluorescence of plasma cells. Each of the five anti-Id MoAbs
appears to recognize the same idiotypic determinant, as was
demonstrated by their identical patterns of reactivity with the
paraprotein panel, and the cross-inhibition of binding to one of
the idiotype-positive monoclonal proteins. The idiotype recog-
nized by the five MoAbs can be classified as a "public" idiotype
[25, 26]. Public idiotypes are shared by antibody molecules with
different antigenic specificities in unrelated individuals, and
may be encoded by germ-line genes. The presence of idiotype
133.5 in normal human serum and colostrum, and the frequency
with which the idiotype is found in PWM-induced plasma cells
from healthy donors support the "public" nature of this idio-
type.
The fact that all five MoAbs recognize the same idiotypic
determinant could suggest that this idiotypic determinant is
dominant in the eluted mesangial IgA of our patient. Alterna-
tively, the selective recognition of a single idiotype in the
process of generating MoAbs could be a result of the limited
immunological repertoire of the mouse strain used. However,
the fact that our attempts to generate a polyclonal anti-idiotypic
Table 4. Idiotype 133.5 prevalence in renal biopsies
Type of glomerulonephritis
Biopsies positive!
biopsies examined
% Positive
biopsies
IgAN 26/31 84
IgAN recurrent in allograft 6/6 100
Henoch-SchOnlein purpura 6/6 100
Lupus glornerulonephritis 8/8 100
Membranous glomerulopathy 7/7 100
Membranoproliferative GN 4/5 80
Essential mixed cryoglobulinemia 3/4 75
Data are numbers of renal biopsies containing 1+ or greater staining
of glomerular deposits for idiotype 133.5, as a fraction of the total
number of biopsies examined in each category.
antiserum in rabbits also failed argues against this latter expla-
nation. The lack of selective affinity of the antiserum for the
mesangial IgA after the absorption to normal immunoglobulin
demonstrates that no idiotypic determinants were recognized
that were not also present in normal human serum. This leaves
open the possibility that the rabbit antiserum originally con-
tained anti-idiotypic antibodies directed at the mesangial IgA,
but that these idiotypes were of a public nature, similar to the
idiotype identified by the five MoAbs. Such public idiotypes are
also present in the normal human immunoglobulin used to
absorb the antiserum, explaining the lack of idiotypic reactivity
after absorption.
The dominance of the single idiotype identified by our five
MoAbs was not supported by the affinity chromatography
experiments. Although the epitope may be immunologically
dominant in that it represents the only idiotype we could
identify, the relative contribution of IgA expressing this idio-
type is rather minor in the renal eluates. The contribution to the
total IgA was 16% in the eluate obtained from isolated glomer-
uli, and below the threshold of detection in the eluate obtained
from the whole renal cortex. This implies that most of the
mesangial IgA expresses a possibly large array of other idio-
types.
Taken together, the results obtained with the polyclonal and
monoclonal antibodies generated against the mesangial IgA of
our patient demonstrate that we were able to identify only a
public idiotype in the glomerular deposits. The study of kidney
biopsies showed that idiotype 133.5 was indeed expressed in the
mesangial deposits in the majority of patients with primary
IgAN, recurrent IgAN after renal transplantation, and Henoch-
SchOnlein purpura. Although this idiotype is shared between
different IgAN patients, it is not specific for this disease, since
it was found with a comparable prevalence in the deposits of
other forms of glomerulonephritis.
Idiotype 133.5 could also be demonstrated in PEG precipi-
tates of sera from IgAN patients. Although the absolute level of
IgA expressing the idiotype was somewhat higher in IgAN
Fig. 3. Immunofluorescence of kidney
biopsies. Immunofluorescence staining of
renal biopsies for IgA and idiotype 133.5. IgA
nephropathy biopsy stained for IgA (A) and
idiotype (B). Henoch Schônlein purpura
biopsy stained for IgA (C) and idiotype (D).
Idiopathic membranous nephritis biopsy
stained for IgA (E) and idiotype (F).
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Table 5. Absorption of renal eluates on MoAb l33.5-Biogel A5
Specimen Idiotype depletion IgA depletion
Glomerular eluate 100% 16%
Cortical eluate 100% 0%
Id IgA myeloma Car 78% 84%
The relative contribution of the idiotype 133.5 in the IgA present in
the specimens was determined by immunoabsorption to immobilized
MoAb 133.5. The fraction removed from the sample by this procedure
is expressed as a percentage of the amount in the material before
absorption.
patients than in controls, no such difference remained when the
levels were corrected for the total amount of IgA present in the
PEG precipitates. This suggests that the relative frequency of
IgA molecules carrying the idiotype is not increased in IgAN
patients. Similarly, the immunofluorescence of plasma cells
showed no selective enhancement of idiotype expression in
IgAN patients compared to healthy controls.
The immunoblotting experiments demonstrate that the idio-
typic determinant recognized by MoAb 133.5 resides on the
light chain. In accordance with this, the idiotype appears to be
restricted to immunoglobulin molecules expressing kappa light
chains. This was shown both by the lack of MoAb 133.5 binding
to lambda monoclonal proteins in ELISA, and by the virtual
absence of idiotype-expressing plasma cells of the lambda chain
type.
We are aware of only one group who previously attempted to
identify IgAN-related idiotypes [19, 201. In these studies, a
rabbit anti-idiotypic serum was generated against BSA-specific
IgG, isolated from the circulation of an IgAN patient. The
idiotype or multiple idiotypes, identified by this polyclonal
antiserum, could be demonstrated in increased quantities com-
pared to healthy controls in the serum of 35 out of 70 IgAN
patients, and in the PEG precipitates in 21 out of 64 [19].
However, this analysis did not take into account that the overall
level of immunoglobulins present in the patient sera and PEG
precipitates may well also be higher in the IgAN patients. In our
study, we also found slightly higher levels of idiotype 133.5 in
PEG precipitates from IgAN patients, but this difference disap-
peared when a correction was made for the total IgA content.
The idiotype(s) identified by the rabbit antiserum could also be
identified in the mesangial deposits of 12 out of 42 IgAN
patients, but in none of 15 patients with membranous or
mesangiocapillary glomerulonephritis [20]. This would suggest
that although the frequency of idiotype expression in the
glomerular deposits is lower than that found in the present
study, the idiotype identified by the polyclonal serum may be
more specific for the disease. Nevertheless, the relevance of the
idiotype remains unclear, mainly because of the method used to
generate the antiserum. The difference may be due to the fact
that the idiotype was not derived from the mesangial IgA, as in
our study, but from the serum. Secondly, the idiotype was
originally expressed on IgG, and not on IgA. Thirdly, the
"offending" idiotype was preselected based on the notion that
anti-BSA antibodies should have some pathogenetic meaning.
In our study, we chose to omit any selection prior to the
generation of the anti-idiotypic MoAbs, and used the total
mesangial IgA preparation. Using this approach, we were
unable to identify any disease-specific idiotype.
The results of our study leave open two possible explanations
for the lack of a disease-specific idiotype. The first is that there
is truly some clonal restriction in the mesangial IgA, as may be
caused by an antigen-driven immune response in IgAN, but that
our methods failed to identify any resulting disease-specific
idiotypes. This possibility seems less likely in view of the fact
that the two different methods (polyclonal rabbit antiserum and
murine MoAbs) yielded comparable results. The second expla-
nation would be that the mesangial IgA is in fact highly
polyclonal in nature, and that we were consequently unable to
detect any clonal restriction. The latter possibility would imply
that a large variety of different antigenic specificities may be
present in the mesangial IgA. The mesangial binding of the IgA
in IgAN could then be the result of the physicochemical binding
of various antigens to the mesangium, followed by in situ
immune complex formation by IgA from the circulation. Evi-
dence for such a highly polyclonal nature of the IgA present in
the serum and renal eluates in IgAN has recently been reported
by others [27]. These findings also cast doubt on the rationale of
some animal models of IgAN in which hyperimmunization with
high doses of a single antigen is used. Alternatively, it may be
that properties of the circulating IgA unrelated to the antigenic
specificity determine the binding to mesangial tissue. Such
properties may include charge, size, abnormal glycosylation, or
presence of molecules associated with the IgA, such as fi-
bronectin [28, 29]. The question of why the IgA adheres to the
mesangium in IgAN is unresolved, and is of paramount impor-
tance for our understanding of the pathogenesis.
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